Evidence map›Paper›PMID 38811852›Full record

ArticleThe EMBO journal2024

Higher-order structure and proteoforms of co-occurring C4b-binding protein assemblies in human serum.

Tereza Kadavá, Johannes F Hevler, Sofia Kalaidopoulou Nteak, Victor C Yin, Juergen Strasser, Johannes Preiner, Albert Jr Heck

Abstract read
In one paragraph

Article in The EMBO journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Knockout of theVeterinary sciences · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tereza KadaváBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, Utrecht, 3584 CH, the Netherlands.ORCID http://orcid.org/0000-0003-3551-7563
Johannes F HevlerBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, Utrecht, 3584 CH, the Netherlands.ORCID http://orcid.org/0000-0001-6636-7145
Sofia Kalaidopoulou NteakBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, Utrecht, 3584 CH, the Netherlands.ORCID http://orcid.org/0009-0002-9442-0040
Victor C YinBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, Utrecht, 3584 CH, the Netherlands.ORCID http://orcid.org/0000-0003-0104-0293
Juergen StrasserUniversity of Applied Sciences Upper Austria, 4020, Linz, Austria.ORCID http://orcid.org/0000-0002-9722-702X
Johannes PreinerUniversity of Applied Sciences Upper Austria, 4020, Linz, Austria.ORCID http://orcid.org/0000-0002-6755-6543
Albert Jr HeckBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, Utrecht, 3584 CH, the Netherlands. a.j.r.heck@uu.nl.ORCID http://orcid.org/0000-0002-2405-4404

Funding

Austrian Science Fund (FWF) P33958Austrian Science Fund (FWF) P34164Austrian Science Fund FWF P 33958Austrian Science Fund FWF P 34164Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) 184.034.019Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) SPI.2017.028
6 · The paper itself

Abstract

The complement is a conserved cascade that plays a central role in the innate immune system. To maintain a delicate equilibrium preventing excessive complement activation, complement inhibitors are essential. One of the major fluid-phase complement inhibitors is C4b-binding protein (C4BP). Human C4BP is a macromolecular glycoprotein composed of two distinct subunits, C4BPα and C4BPβ. These associate with vitamin K-dependent protein S (ProS) forming an ensemble of co-occurring higher-order structures. Here, we characterize these C4BP assemblies. We resolve and quantify isoforms of purified human serum C4BP using distinct single-particle detection techniques: charge detection mass spectrometry, and mass photometry accompanied by high-speed atomic force microscopy. Combining cross-linking mass spectrometry, glycoproteomics, and structural modeling, we report comprehensive glycoproteoform profiles and full-length structural models of the endogenous C4BP assemblies, expanding knowledge of this key complement inhibitor's structure and composition. Finally, we reveal that an increased C4BPα to C4BPβ ratio coincides with elevated C-reactive protein levels in patient plasma samples. This observation highlights C4BP isoform variation and affirms a distinct role of co-occurring C4BP assemblies upon acute phase inflammation.

Indexed as

Complement C4b-Binding ProteinC-Reactive ProteinHistocompatibility AntigensHumansMass SpectrometryMicroscopy, Atomic ForceModels, MolecularProtein ConformationProtein IsoformsC4BPA protein, humanC4BPB protein, humanComplement C4b-Binding ProteinC-Reactive ProteinHistocompatibility AntigensProtein IsoformsC4b-Binding ProteinComplementIntegrative Structural ModelingMass Spectrometry-Based Techniques

Identifiers

PMID38811852
PMCPMC11251186

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.